Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

"Influx" of atypical myopathy cases
horse
Research has linked toxins in the seeds of sycamore trees to atypical myopathy.
Vets advise restricted access to sycamore

Newmarket vets have seen "an influx" of horses with equine atypical myopathy (AM) and are warning owners to restrict access to sycamore trees, which have been linked to the potentially lethal condition.

Over the past week, Rossdales Equine Hospital says it has seen several cases of the muscle disease, all of which were sycamore related.

Past research suggests AM is likely to be caused by ingestion of sycamore tree seeds, which contain the toxin hypoglycin-A. The condition is thought to be particularly common after periods of wet and windy weather.

Rossdales' internal medicine specialist, Professor Celia Marr, said recent weather conditions are likely to have been "an additional trigger factor."

She added: "We would recommend removing access to sycamore and providing supplementary feed during bad weather - both are appropriate measures."

AM causes the destruction of muscle tissue, including the heart. Dark coloured urine is "a characteristic sign," said Professor Marr. The presenting sign in about 10 to 20 per cent of patients is sudden stiffness or difficulty swallowing.

Other signs include muscle tremors, breathing problems, sudden weakness and low body temperature.

Swift treatment and careful management is essential in AM cases.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'